Revolutionary Pancreatic Cancer Drug Shows Unprecedented Success

A new drug, daraxonrasib, targeting the KRAS oncogene, is showing unprecedented success in treating pancreatic cancer, according to experts.

Post Share

Sources

Showing 0 of 1 sources

No articles available in your preferred languages.

1 article available in other languages below.

el-mundoSpanish37d ago

Así es el revolucionario fármaco para cáncer de páncreas que ya empieza a beneficiar al enfermo

La diana del fármaco daraxonrasib es el oncogén KRAS. Dos expertas en este tumor analizan el "éxito sin precedentes" de la nueva molécula que se dirige a la vía esencial en cáncer de páncreas Leer

Read full article →

PERSPECTA

PERSPECTA

Revolutionary Pancreatic Cancer Drug Shows Unprecedented Success

Sources

Así es el revolucionario fármaco para cáncer de páncreas que ya empieza a beneficiar al enfermo

Related Stories

Oldest Known Plague Outbreak Discovered in Siberia Dating Back 5,500 Years

Extreme Training: What Heat Training Does to the Body

200 Young Campers Rescued Amid Flooding in Missouri and Kentucky

Martha Lillard, Last American Iron Lung User, Dies at 78

PERSPECTA